226 related articles for article (PubMed ID: 36588432)
1. Systematic Review and Meta-Analysis of Damage Associated Molecular Patterns HMGB1 and S100B in Schizophrenia.
Mackey M; Holleran L; Donohoe G; McKernan DP
Psychiatry Investig; 2022 Dec; 19(12):981-990. PubMed ID: 36588432
[TBL] [Abstract][Full Text] [Related]
2. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis.
Halstead S; Siskind D; Amft M; Wagner E; Yakimov V; Shih-Jung Liu Z; Walder K; Warren N
Lancet Psychiatry; 2023 Apr; 10(4):260-271. PubMed ID: 36863384
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia.
Kozłowska E; Brzezińska-Błaszczyk E; Agier J; Wysokiński A; Żelechowska P
J Psychiatr Res; 2021 Jun; 138():380-387. PubMed ID: 33957300
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and meta-analysis of circulating S100B blood levels in schizophrenia.
Aleksovska K; Leoncini E; Bonassi S; Cesario A; Boccia S; Frustaci A
PLoS One; 2014; 9(9):e106342. PubMed ID: 25202915
[TBL] [Abstract][Full Text] [Related]
6. Elevated Blood S100B Levels in Patients With Migraine: A Systematic Review and Meta-Analysis.
Chu C; Zhong R; Cai M; Li N; Lin W
Front Neurol; 2022; 13():914051. PubMed ID: 35911929
[TBL] [Abstract][Full Text] [Related]
7. Increased Serum S100B Levels in Patients With Epilepsy: A Systematic Review and Meta-Analysis Study.
Liang KG; Mu RZ; Liu Y; Jiang D; Jia TT; Huang YJ
Front Neurosci; 2019; 13():456. PubMed ID: 31156363
[No Abstract] [Full Text] [Related]
8. Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia-A Meta-Regression Analysis.
Schümberg K; Polyakova M; Steiner J; Schroeter ML
Front Cell Neurosci; 2016; 10():46. PubMed ID: 26941608
[TBL] [Abstract][Full Text] [Related]
9. Peripheral Blood S100B Levels in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis.
Zheng Z; Zheng P; Zou X
J Autism Dev Disord; 2021 Aug; 51(8):2569-2577. PubMed ID: 33006697
[TBL] [Abstract][Full Text] [Related]
10. S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study.
Steiner J; Bernstein HG; Bielau H; Farkas N; Winter J; Dobrowolny H; Brisch R; Gos T; Mawrin C; Myint AM; Bogerts B
J Psychiatr Res; 2008 Aug; 42(10):868-76. PubMed ID: 18001771
[TBL] [Abstract][Full Text] [Related]
11. The effect of obstructive sleep apnea syndrome on serum S100B and NSE levels: a systematic review and meta-analysis of observational studies.
Rezaei F; Abbasi H; Sadeghi M; Imani MM
BMC Pulm Med; 2020 Feb; 20(1):31. PubMed ID: 32024492
[TBL] [Abstract][Full Text] [Related]
12. Systematic Review and Meta-Analysis of Damage Associated Molecular Patterns HMGB1 and S100B in Schizophrenia.
Mackey M; Holleran L; Donohoe G; McKernan DP
Psychiatry Investig; 2024 Jan; 21(1):109. PubMed ID: 38281740
[No Abstract] [Full Text] [Related]
13. Diagnostic and prognostic value of serum S100B in sepsis-associated encephalopathy: A systematic review and meta-analysis.
Hu J; Xie S; Li W; Zhang L
Front Immunol; 2023; 14():1102126. PubMed ID: 36776893
[TBL] [Abstract][Full Text] [Related]
14. Serum S100B in manic bipolar disorder patients: Systematic review and meta-analysis.
da Rosa MI; Simon C; Grande AJ; Barichello T; Oses JP; Quevedo J
J Affect Disord; 2016 Dec; 206():210-215. PubMed ID: 27475892
[TBL] [Abstract][Full Text] [Related]
15. Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia.
Chen S; Tian L; Chen N; Xiu M; Wang Z; Yang G; Wang C; Yang F; Tan Y
Psychiatry Res; 2017 Jan; 247():6-11. PubMed ID: 27863321
[TBL] [Abstract][Full Text] [Related]
16. Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia.
Milleit B; Smesny S; Rothermundt M; Preul C; Schroeter ML; von Eiff C; Ponath G; Milleit C; Sauer H; Gaser C
Front Cell Neurosci; 2016; 10():33. PubMed ID: 27013967
[TBL] [Abstract][Full Text] [Related]
17. Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia--original research and meta-analysis.
Schroeter ML; Abdul-Khaliq H; Krebs M; Diefenbacher A; Blasig IE
Psychiatry Res; 2009 May; 167(1-2):66-72. PubMed ID: 19375171
[TBL] [Abstract][Full Text] [Related]
18. Higher Plasma S100B Concentrations in Schizophrenia Patients, and Dependently Associated with Inflammatory Markers.
Hong W; Zhao M; Li H; Peng F; Wang F; Li N; Xiang H; Su Y; Huang Y; Zhang S; Zhao G; Zhou R; Mao L; Lin Z; Fang Y; Zhang Q; Xie B
Sci Rep; 2016 Jun; 6():27584. PubMed ID: 27279465
[TBL] [Abstract][Full Text] [Related]
19. Peripheral S100B Protein Levels in Five Major Psychiatric Disorders: A Systematic Review.
Kozlowski T; Bargiel W; Grabarczyk M; Skibinska M
Brain Sci; 2023 Sep; 13(9):. PubMed ID: 37759935
[TBL] [Abstract][Full Text] [Related]
20. Serum S100B is increased during early treatment with antipsychotics and in deficit schizophrenia.
Schroeter ML; Abdul-Khaliq H; Frühauf S; Höhne R; Schick G; Diefenbacher A; Blasig IE
Schizophr Res; 2003 Aug; 62(3):231-6. PubMed ID: 12837519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
